Home/Filings/4/0001209191-21-040339
4//SEC Filing

ROCHE ROBERT P JR 4

Accession 0001209191-21-040339

CIK 0001016169other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 6:25 PM ET

Size

9.1 KB

Accession

0001209191-21-040339

Insider Transaction Report

Form 4
Period: 2021-06-10
Transactions
  • Award

    Common Stock

    2021-06-10$4.42/sh+25,452$112,498167,817 total
  • Award

    Stock Option (right to buy)

    2021-06-10+48,54248,542 total
    Exercise: $4.42Exp: 2031-06-10Common Stock (48,542 underlying)
Footnotes (3)
  • [F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest one year from the grant date.
  • [F2]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
  • [F3]The options vest and become exercisable one year from the grant date.

Issuer

ANTARES PHARMA, INC.

CIK 0001016169

Entity typeother

Related Parties

1
  • filerCIK 0001210193

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:25 PM ET
Size
9.1 KB